Literature DB >> 21460865

Deferasirox increases BU blood concentrations.

K Sweiss, P Patel, D Rondelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21460865     DOI： 10.1038/bmt.2011.75

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.

Authors:  Benigno C Valdez; Moustapha Hassan; Borje S Andersson
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

Review 2.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481

3.  External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Huiping Huang; Qingxia Liu; Xiaohan Zhang; Helin Xie; Maobai Liu; Nupur Chaphekar; Xuemei Wu
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

Review 4.  Clinical pharmacology of deferasirox.

Authors:  Chiaki Tanaka
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 5.577
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.